Skip to content

Clinical Performance of Masimo INVSENSOR00048

Clinical Performance of Masimo INVSENSOR00048

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06289556
Enrollment
180
Registered
2024-03-04
Start date
2024-01-23
Completion date
2025-05-19
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fever, Healthy

Brief summary

The objective of this clinical study is to validate temperature performance of the noninvasive Masimo INVSENSOR00048.

Interventions

DEVICEMasimo INVSENSOR00048

Masimo INVSENSOR00048 will be used to collect temperature measurements.

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SEQUENTIAL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Afebrile subjects of all ages, or febrile subjects of all ages who meet the following criteria for screening temperature: * sublingual temperature ≥ 37.5°C (99.5°F), * rectal temperature ≥ 38.0°C (100.4°F), * or axillary temperature ≥ 37.2°C (99.0°F) * If subject is \< 18 years old, parents or legally authorized representatives (LAR) have provided informed consent and have signed all necessary related documents

Exclusion criteria

* Subjects with medical conditions such as inflammation at the measuring site or taking medications e.g. barbiturates, thyroid preparations, antipsychotics, or immunization within prior 7 days, which might skew clinical accuracy validation results such as, per the investigator's judgement * Subjects unable to provide informed consent or assent, as appropriate * Subjects with conditions at or around site of sensor placement or skin abnormalities affecting the sensor placement area such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown that would prevent monitoring of physiological parameters during the study * Subjects with known allergies to adhesive material used in medical equipment * Subjects with medical conditions which, in the judgment of the investigator, renders them inappropriate for participation in this study * Excluded at the Principal Investigator's discretion

Design outcomes

Primary

MeasureTime frameDescription
Clinical Performance of Masimo INVSENSOR00048Approximately 90 minutesThe outcome measure is determination of the Masimo INVSENSOR00048 temperature performance by comparing the Clinical Bias and Limits of Agreement (LOA) between the corresponding adjustment mode temperature of the INVSENSOR00048 and reference thermometer in degrees celsius. Clincal Bias is defined as mean difference between output temperatires of a clinical thermometer and a reference clinical thermometer for the intended reference body site with specified limitis of agreement when measured from selected group of subjects . Limits of agreement is defined as the magnitude of a potential disagreement between outputs of two clinical thermometers equal to double the standard deviation of output temperate differences when used on the same human subject .

Countries

United States

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
109 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants
Race (NIH/OMB)
Asian
10 Participants
Race (NIH/OMB)
Black or African American
4 Participants
Race (NIH/OMB)
More than one race
5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
2 Participants
Race (NIH/OMB)
Unknown or Not Reported
21 Participants
Race (NIH/OMB)
White
66 Participants
Sex: Female, Male
Female
71 Participants
Sex: Female, Male
Male
38 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 180
other
Total, other adverse events
1 / 180
serious
Total, serious adverse events
0 / 180

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026